Search

Your search keyword '"Lapadula, C."' showing total 2 results
Start Over Author "Lapadula, C." Language italian
2 results on '"Lapadula, C."'

1. [Hormone therapies in pregnancy]

Author

G A, Tommaselli, M, Pellicano, M, Guida, S, Palomba, F, Savarese, B, Nola, C, Ferrara, C, Lapadula, C, Nappi, Tommaselli, Ga, Pellicano, Massimiliano, Guida, Maurizio, Palomba, S, Savarese, F, Nola, B, Ferrara, C, Lapadula, C, and Nappi, Carmine

Subjects
Adult, Hypoparathyroidism, Hyperparathyroidism, Infant, Newborn, Abnormalities, Drug-Induced, Endocrine System Diseases, Hyperthyroidism, Risk Assessment, Hormones, Pregnancy Complications, Fetus, Addison Disease, Hypothyroidism, Pregnancy, Acromegaly, Hypercalcemia, Humans, Female, Pituitary Neoplasms, Prolactinoma, Child, Cushing Syndrome, Pregnancy Complications, Neoplastic, Diabetes Insipidus
Abstract

Maternal endocrine disorders can have detrimental effects on the fetus and the pregnancy can affect the course of a pre-exisiting endocrinopathy or induce the onset of one of these disorders. Therapies for endocrine disorders are not always safe to administer during pregnancy. Before administering any therapy to the mother, the effects on the fetus, the degree of placental trespassing as well as the potential damaging effects must be assessed. An accurate evaluation of the risks/benefits of any drug to be used on the mother is needed, assessing above all a potential theratogenic effect. In this review, the incidence of the main endocrine disorders, their evolution during pregnancy, their effects on mothers and fetuses and new acquisition on the treatment during pregnancy are discussed.

Published
2002

2. [Hormone therapies in pregnancy].

Author

Tommaselli GA, Pellicano M, Guida M, Palomba S, Savarese F, Nola B, Ferrara C, Lapadula C, and Nappi C

Subjects
Acromegaly drug therapy, Addison Disease drug therapy, Adult, Child, Cushing Syndrome drug therapy, Diabetes Insipidus drug therapy, Female, Hormones adverse effects, Humans, Hypercalcemia drug therapy, Hyperparathyroidism drug therapy, Hyperthyroidism drug therapy, Hypoparathyroidism drug therapy, Hypothyroidism drug therapy, Infant, Newborn, Pituitary Neoplasms drug therapy, Pituitary Neoplasms surgery, Pregnancy, Pregnancy Complications, Neoplastic drug therapy, Pregnancy Complications, Neoplastic surgery, Prolactinoma drug therapy, Prolactinoma surgery, Risk Assessment, Abnormalities, Drug-Induced etiology, Endocrine System Diseases drug therapy, Fetus drug effects, Hormones therapeutic use, Pregnancy Complications drug therapy
Abstract

Maternal endocrine disorders can have detrimental effects on the fetus and the pregnancy can affect the course of a pre-exisiting endocrinopathy or induce the onset of one of these disorders. Therapies for endocrine disorders are not always safe to administer during pregnancy. Before administering any therapy to the mother, the effects on the fetus, the degree of placental trespassing as well as the potential damaging effects must be assessed. An accurate evaluation of the risks/benefits of any drug to be used on the mother is needed, assessing above all a potential theratogenic effect. In this review, the incidence of the main endocrine disorders, their evolution during pregnancy, their effects on mothers and fetuses and new acquisition on the treatment during pregnancy are discussed.

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results